Content about pharmaceutical

August 20, 2013

Generic drug maker Sandoz has relaunched a website to promote its biosimilars business.

NEW YORK — Generic drug maker Sandoz has relaunched a website to promote its biosimilars business.

August 15, 2013

Boehringer Ingelheim, a research-based, global pharmaceutical company, today announced a multi-year agreement with Brigham and Women's Hospital on a long-term study program to assess comparative effectiveness and safety, as well as prescribing patterns, of oral anticoagulants, including Pradaxa, for the reduction of stroke risk in U.S. patients with non-valvular atrial fibrillation.

RIDGEFIELD, Conn. — Boehringer Ingelheim, a research-based, global pharmaceutical company, today announced a multi-year agreement with Brigham and Women's Hospital on a long-term study program to assess comparative effectiveness and safety, as well as prescribing patterns, of oral anticoagulants, including Pradaxa, for the reduction of stroke risk in U.S. patients with non-valvular atrial fibrillation.

August 15, 2013

Eisai, the U.S. pharmaceutical arm of Tokyo-based Eisai Co., announced the launch of a new website, "Closing the Gap: Obesity Management for Employers," to provide employers with an educational resource for information about obesity management.

WOODCLIFF LAKE, N.J. — Eisai Inc., the U.S. pharmaceutical arm of Tokyo-based Eisai Co. Ltd., announced on Thursday the launch of a new website, "Closing the Gap: Obesity Management for Employers," to provide employers with an educational resource for information about obesity management.

August 14, 2013

In its first year, more than 20,000 schools across all 50 states participated in the program that offers four free EpiPen or EpiPen Jr (epinephrine) Auto-Injectors to qualifying schools in the United States.

BASKING RIDGE, N.J. — Mylan Specialty, the fully integrated specialty pharmaceutical business of Mylan, today announced a second year of its EpiPen4Schools program. In its first year, more than 20,000 schools across all 50 states participated in the program that offers four free EpiPen or EpiPen Jr (epinephrine) Auto-Injectors to qualifying schools in the United States. Qualifications include having a valid prescription.

August 13, 2013

The U.S. Food and Drug Administration this past weekend announced new fee rates for fiscal year 2014, including the abbreviated new drug application fee.

WASHINGTON — The U.S. Food and Drug Administration this past weekend announced new fee rates for fiscal year 2014, including the abbreviated new drug application fee.

August 12, 2013

The new private-label dressing is based on the Medihoney HCS dressing, which is an ideal dressing for dry to lightly exuding wounds including minor burns, cuts and abrasions. The dressing is expected to be on the shelves in more than 4,000 stores by the end of September.

PRINCETON, N.J. — Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today reported that it has made an initial shipment of its first honey-based over-the-counter product to a leading U.S.-based pharmacy chain. This private-label dressing is based on the Medihoney HCS dressing, which is an ideal dressing for dry to lightly exuding wounds including minor burns, cuts and abrasions. The dressing is expected to be on the shelves in more than 4,000 stores by the end of September.

August 8, 2013

One of the fastest-growing segments in health care today is home health care, which is expected to become even more important over the next decade. To help independent pharmacies take advantage of the market, Cardinal Health is giving its customers access to more than 30,000 medical products through Independence Medical, the company said at its annual Retail Business Conference for independent pharmacy owners.

SEATTLE — One of the fastest-growing segments in health care today is home health care, which is expected to become even more important over the next decade. To help independent pharmacies take advantage of the market, Cardinal Health is giving its customers access to more than 30,000 medical products through Independence Medical, the company said Friday, here in Seattle, at its annual Retail Business Conference for independent pharmacy owners.

August 8, 2013

Can one of the nation's premier specialty pharmacies maintain its focus on each patient it serves while simultaneously smashing its own growth records and reaching national power-player status in the rarified world of specialized medication services?

Can one of the nation's premier specialty pharmacies maintain its focus on each patient it serves while simultaneously smashing its own growth records and reaching national power-player status in the rarified world of specialized medication services?

August 8, 2013

Any specialty pharmacy provider that wants to succeed in today's healthcare arena has to align its capabilities with patients, prescribing physicians, hospitals and pharmaceutical manufacturers. But success also depends on delivering cost savings and high-touch patient care services to managed care and health plan payers that depend on it.

Any specialty pharmacy provider that wants to succeed in today's healthcare arena has to align its capabilities with patients, prescribing physicians, hospitals and pharmaceutical manufacturers. But success also depends on delivering cost savings and high-touch patient care services to managed care and health plan payers that depend on it.

August 8, 2013

For traditional retail pharmacies, one of the biggest roadblocks to entry into the specialty arena is the limited availability of many complex medicines.

For traditional retail pharmacies, one of the biggest roadblocks to entry into the specialty arena is the limited availability of many complex medicines. More and more of these high-ticket, high-touch drugs are entering the market via very restricted and exclusive networks as pharmaceutical manufacturers increasingly demand that the pharmacies dispensing those medicines demonstrate advanced clinical, documentation and patient-support capabilities, including the ability to improve adherence rates, conduct risk evaluation and mitigation strategies, and manage and monitor patient outcomes.

August 8, 2013

The Supreme Court usually has a lot on its plate in any given year, but this year's term included a pretty big case for the pharmaceutical industry: the Federal Trade Commission v. Actavis, which concerned legal settlements between branded and generic drug makers that often occur when the latter attempts to market a generic drug before the former's patents have expired.

The Supreme Court usually has a lot on its plate in any given year, but this year's term included a pretty big case for the pharmaceutical industry: the Federal Trade Commission v. Actavis, which concerned legal settlements between branded and generic drug makers that often occur when the latter attempts to market a generic drug before the former's patents have expired.

August 8, 2013

The urgency behind Diplomat's launch of its Retail Specialty Network isn't hard to fathom. As the growth momentum in pharmaceuticals shifts from traditionally developed drugs to more complex and expensive specialty and biotech products, traditional pharmacies without access to these specialized medicines — and the patients who depend on them — find themselves stranded in a receding market like boats at low tide.

The urgency behind Diplomat's launch of its Retail Specialty Network isn't hard to fathom. As the growth momentum in pharmaceuticals shifts from traditionally developed drugs to more complex and expensive specialty and biotech products, traditional pharmacies without access to these specialized medicines — and the patients who depend on them — find themselves stranded in a receding market like boats at low tide.

August 8, 2013

Mike Aigner, director of national accounts, Mylan
Q: What do you hope to get out of the RBC show?
A: We'd like to reach as many customers as possible. Cardinal has been an absolutely great partner for many years.

July 30, 2013

Big data finds another application and another supporter. Sort of.

The full Senate will shortly take up a new track-and-trace bill (S. 959), which would establish a national system for tracking the pedigree and movement of most pharmaceuticals, from point of manufacture and distribution to the dispensing pharmacy and the patient at the end of the supply chain. The goal: to replace the hodge-podge of different state laws with a single, nationwide track-and-trace system capable of capturing the daily flood of drug production, distribution, dispensing and utilization data and channeling it into an accessible tool by which stakeholders and regulators could secure the pharmaceutical supply chain.

Big data finds another application and another supporter. Sort of.

July 26, 2013

With the 2013 Cardinal Health Retail Business Conference approaching, Drug Store News sat down with George Barrett, chairman and CEO of Cardinal Health, to discuss the company’s commitment to independent pharmacy.

With the 2013 Cardinal Health Retail Business Conference approaching, Drug Store News sat down with George Barrett, chairman and CEO of Cardinal Health, to discuss the company’s commitment to independent pharmacy.

DSN: What do you see as the most significant challenges facing independent pharmacies today?

July 26, 2013

A new track-and-trace bill that the Senate is expected to consider would institute a nationwide "track-and-trace" system in place of patchwork state laws with the aim of securing the pharmaceutical supply chain.

ALEXANDRIA, Va. — A new track-and-trace bill that the Senate is expected to consider would institute a nationwide "track-and-trace" system in place of patchwork state laws with the aim of securing the pharmaceutical supply chain.

S. 959 also seeks to respond to last year's meningitis outbreak by establishing a list of "do not compound" medications.

July 25, 2013

H. D. Smith on Thursday announced the completion of the deal to attain majority interest in Triplefin, a reimbursement, patient assistance and pharmaceutical brand-support services company headquartered in Cincinnati.

SPRINGFIELD, Ill. — H. D. Smith on Thursday announced the completion of the deal to attain majority interest in Triplefin, a reimbursement, patient assistance and pharmaceutical brand-support services company headquartered in Cincinnati.  

July 25, 2013

Distribution Solutions revenues were up 5% in the first quarter, driven mainly by strong growth in U.S. pharmaceutical direct distribution and services revenues and the acquisition of PSS World Medical. Technology Solutions revenues were up 9% in the first quarter compared to the prior year.

SAN FRANCISCO — McKesson on Thursday afternoon reported revenues of $32.2 billion, up 5%, for the first quarter ended June 30.

July 16, 2013

The National Community Pharmacists Association CEO Douglas Hoey testified Tuesday before the U.S. House of Representatives Energy and Commerce Subcommittee on Health’s hearing on “Reforming the Drug Compounding Regulatory Framework.”

ALEXANDRIA, Va. — The National Community Pharmacists Association CEO Douglas Hoey testified Tuesday before the U.S. House of Representatives Energy and Commerce Subcommittee on Health’s hearing on “Reforming the Drug Compounding Regulatory Framework.”  

His remarks focused on discussion draft legislation offered by U.S. Rep. Morgan Griffith, R-Va., that seeks to address the concerns raised by the New England Compounding Center’s fungal meningitis tragedy late last year. 

July 8, 2013

AmerisourceBergen announced that its national network of Good Neighbor Pharmacy owners and more than 250 exhibitors from across the pharmaceutical supply chain will be on hand July 24 to 27 in Las Vegas for ThoughtSpot 2013.

VALLEY FORGE, Pa. — AmerisourceBergen on Monday announced that its national network of Good Neighbor Pharmacy owners and more than 250 exhibitors from across the pharmaceutical supply chain will be on hand July 24 to 27 in Las Vegas for ThoughtSpot 2013.

July 2, 2013

UrgentRx on Monday named Michael Valentino to the company's board.

DENVER — UrgentRx on Monday named Michael Valentino to the company's board. Valentino brings more than 30 years of leadership experience at both major pharmaceutical companies and venture-backed start-ups. His most recent commercial responsibility was with Xanodyne Pharmaceuticals as president and CEO, UrgentRx reported. 

June 20, 2013

Pharmaceutical wholesaler H.D. Smith will buy a majority interest in a Cincinnati-based patient assistance, pharmaceutical brand support and reimbursement company.

SPRINGFIELD, Ill. – Pharmaceutical wholesaler H.D. Smith will buy a majority interest in a Cincinnati-based patient assistance, pharmaceutical brand support and reimbursement company.

The wholesaler said Thursday that it had originally acquired majority board representation in Triplefin and would secure majority stock ownership in it. Financial terms of the deal were not disclosed.

June 18, 2013

Half a loaf, the saying goes, is better than none. For the generic drug industry, that means that the Supreme Court handed it a partial victory Monday by ruling that “pay for delay” patent settlements between brand name and generic drug companies aren’t necessarily illegal and should be considered on a case-by-case, “rule of reason” approach by the Federal Trade Commission, which staunchly opposes the practice.

Half a loaf, the saying goes, is better than none. For the generic drug industry, that means that the Supreme Court handed it a partial victory Monday by ruling that “pay for delay” patent settlements between brand name and generic drug companies aren’t necessarily illegal and should be considered on a case-by-case, “rule of reason” approach by the Federal Trade Commission, which staunchly opposes the practice.

June 17, 2013

One of the greatest challenges facing the pharmaceutical industry today is medication nonadherence — a fact that has not gone unnoticed by McKesson.

A variety of pharmacy-based solutions, designed to help pharmacy owners drive better results both from a patient outcomes and a profitability standpoint by offering services that promote long-term adherence and opportunities for patients to enroll in clinical trials, will be on display for ideaShare attendees through McKesson’s Clinical Services network.

SCOTTSDALE, Ariz. — One of the greatest challenges facing the pharmaceutical industry today is medication non-adherence — a fact that has not gone unnoticed by McKesson.

A variety of pharmacy-based solutions, designed to help pharmacy owners drive better results both from a patient outcomes and a profitability standpoint by offering services that promote long-term adherence and opportunities for patients to enroll in clinical trials, will be on display for ideaShare attendees through McKesson’s Clinical Services network.

June 13, 2013

Drug maker Actavis is working with nonprofit pharmaceutical company Medicines360 to make low-cost intrauterine devices available to women, the two said.

PARSIPPANY, N.J. — Drug maker Actavis is working with nonprofit pharmaceutical company Medicines360 to make low-cost intrauterine devices available to women, the two said.